Mapping ovarian cancer sentinel nodes with two injected dyes
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study checks whether doctors can find the first lymph node(s) where ovarian cancer may spread using two dyes (a radioactive tracer and a green dye). It may help surgeons do more precise staging and treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an ovarian/adnexal mass that is suspected to be cancer or you have early-stage epithelial ovarian cancer confirmed by pathology
- Your pre-surgery scans do not show spread to the back of the belly (retroperitoneal) or other distant metastatic disease
- You can have surgery and a tumor/biopsy is possible during the operation
- You are not pregnant or breastfeeding
- If you could become pregnant, you can use very effective birth control (including partner vasectomy or no sex) until the last study visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a technique that uses a special dye to find the first lymph nodes where ovarian cancer might spread. It aims to help doctors remove only those sentinel nodes during surgery instead of removing many nodes, which could lead to fewer side effects.
This study tests a way to check for cancer spread in the lymph nodes of the pelvis during surgery for early-stage ovarian cancer. It uses a special dye and tracer to find the first lymph node that drains from the tumor.
This study tests a technique to find the first lymph nodes that might contain cancer cells during surgery for early-stage ovarian cancer. It aims to see if this method can help doctors remove fewer lymph nodes while still getting important information.
This study is testing a blue dye called Patent Blue to see if it can help surgeons find sentinel lymph nodes (the first nodes cancer might spread to) during surgery for early-stage ovarian cancer. The goal is to reduce the need for more extensive lymph node removal, possibly leading to fewer side effects.
This trial tests whether injecting a dye called indocyanine green (ICG) in different spots can better find sentinel lymph nodes during surgery for endometrial cancer. It may help doctors remove fewer nodes and reduce side effects.
This trial studies whether taking a sample from the sentinel lymph node during surgery can help with staging early ovarian cancer. It may help doctors find spread to lymph nodes more accurately while limiting unnecessary lymph node removal in some cases.
Hear when a new Ovarian Epithelial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.